Holen Sie sich die Stockscreener-App
1.22
12.96%
0.14
Finanzdaten der Alx Oncology Holdings Inc-Aktie (ALXO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
16.25%
26.65
|
31.82 | 30.61 | 32.57 | 41.52 |
| Interest Income/Expense |
0.25%
0.405
|
0.406 | 0.427 | 0.446 | 0.429 |
| Depreciation and Amortization |
0.00%
0.20
|
0.20 | 0.20 | 0.20 | 0.20 |
| Operating Income/Loss |
16.25%
-26.65
|
-31.82 | -30.61 | -32.57 | -41.52 |
| Income/Loss From Continuing Operations Before Tax |
15.62%
-25.95
|
-30.75 | -29.16 | -30.71 | -39.40 |
| Income/Loss From Continuing Operations After Tax |
15.62%
-25.95
|
-30.75 | -29.16 | -30.71 | -39.40 |
|
Net Income/Loss
|
15.62%
-25.95
|
-30.75 | -29.16 | -30.71 | -39.40 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.16%
53.45
|
53.36 | 0.6304 | 52.69 | 51.83 |
| Diluted Average Shares |
0.16%
53.45
|
53.36 | 0.6304 | 52.69 | 51.83 |
| Basic Earnings Per Share |
15.52%
-0.49
|
-0.58 | -0.53 | -0.58 | -0.76 |
| Diluted Earnings Per Share |
15.52%
-0.49
|
-0.58 | -0.53 | -0.58 | -0.76 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):